Document Detail

Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.
MedLine Citation:
PMID:  17070179     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Whereas C-reactive protein (CRP) is a nonspecific marker of coronary artery disease (CAD) and cardiovascular (CV) events, Lp-PLA2 may be a nonvariable inflammatory biomarker. We evaluated the independent association of lipoprotein-associated phospholipase A2 (Lp-PLA2) to angiographic CAD and CV events adjusting for standard factors, lipids, and CRP. METHODS: Lipoprotein-associated phospholipase A2 (PLAC test, diaDexus, Inc, San Francisco, CA) and CRP were measured from samples donated by consecutive consenting patients (N = 1493) enrolled in the registry of the Intermountain Heart Collaborative Study. All patients underwent coronary angiography (1996-1998) for CAD determination and were followed for 6.7 +/- 0.5 years (range 5.7-7.9 years) for CV events (death [including all-cause, CAD, and non-CAD CV death], myocardial infarction, and cerebrovascular accident). RESULTS: Lipoprotein-associated phospholipase A2 weakly correlated with lipids (low-density lipoprotein: r = 0.22, P < .001; high-density lipoprotein: r = -0.13, P < .001), but not CRP (r = 0.03, P = .26). Increasing quartile (Q) of Lp-PLA2 predicted greater the presence of CAD (vs Q1) for Q2 (adjusted odds ratio [OR] 1.15, 95% CI 0.78-1.71, P = .48), for Q3 (OR 1.53, 95% CI 1.02-2.31, P = .042), and for Q4 (OR 2.44, 95% CI 1.58-3.79, P < .001), although CRP was also predictive (vs Q1, Q2: OR 1.47, P = .057; Q3: OR 1.93, P = .002; Q4: OR 3.43, P < .001). In Cox regression, Lp-PLA2 predicted CAD death (vs Q1; Q2: adjusted hazard ratio [HR] 1.27, 95% CI 0.58-2.78, P = .55; Q3: HR 2.18, 95% CI 1.04-4.57, P = .04; Q4: HR 1.73, 95% CI 0.84-3.61, P = .14). CONCLUSION: Lipoprotein-associated phospholipase A2 was confirmed to predict the presence of CAD, even among patients undergoing coronary angiography. Uniquely, Lp-PLA2 predicted the risk of CAD death, but not all-cause death, myocardial infarction, or cerebrovascular accident.
Heidi T May; Benjamin D Horne; Jeffrey L Anderson; Robert L Wolfert; Joseph B Muhlestein; Dale G Renlund; Jessica L Clarke; Matthew J Kolek; Tami L Bair; Robert R Pearson; Krishnankutty Sudhir; John F Carlquist
Related Documents :
1732399 - Lack of association between the apolipoprotein b gene 3' hypervariable region alleles a...
9605599 - Benefits of combination therapy in hypertensive patients with associated coronary arter...
20815059 - Negative predictive value of normal adenosine-stress cardiac mri in the assessment of c...
8465739 - Identification of high-risk patients with left main and three-vessel coronary artery di...
21503789 - Atp-dependent potassium channels and mitochondrial permeability transition pores play r...
25296909 - Coronary atheroma composition and its association with segmental endothelial dysfunctio...
1279529 - Modification of late potentials by intracoronary ethanol infusion.
2992889 - Mitral valve e-point septal separation as an indicator of ejection fraction in patients...
19853229 - Acute limb ischemia.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American heart journal     Volume:  152     ISSN:  1097-6744     ISO Abbreviation:  Am. Heart J.     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-10-30     Completed Date:  2006-11-30     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  997-1003     Citation Subset:  AIM; IM    
Cardiovascular Department, LDS Hospital, Salt Lake City, UT 84143, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
1-Alkyl-2-acetylglycerophosphocholine Esterase
Coronary Angiography
Coronary Artery Disease / blood,  mortality*,  radiography*
Middle Aged
Phospholipases A / blood*
Phospholipases A2
Predictive Value of Tests
Reg. No./Substance:
EC 3.1.1.-/Phospholipases A; EC A2; EC Esterase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Anemia as independent predictor of major events in elderly patients with chronic angina.
Next Document:  Prognostic implication of valvular lesion and left ventricular size in asymptomatic patients with ch...